Read more about this at the At Risk for Huntington's Disease Blog
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease,
Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic...
Statement from Roche and AAN Huntington’s Community
Statement from Roche and AAN Huntington's Community as originally reported on We Have a Face Global Times, read more here.